Fact CheckerSign in

NCT06534658Recruiting

Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia

Source: ClinicalTrials.gov · Last updated 2 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This project is a multicenter observational study that establishes a longitudinal cohort of patients with Alzheimer's disease and other dementias based on neuroimaging, molecular imaging, biological and digital markers to explore new solutions such as dementia disease mechanism, diagnosis, condition evaluation, and prognosis assessment.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1000 (estimated)
First submitted
18 Jul 2024
Start date
30 Jul 2020
Primary completion date
30 Jul 2029
Lead sponsor
Ruijin Hospital
NCT number
NCT06534658

What you commit to

  • Study type: Observational
  • Planned participants: 1000
  • From 30 Jul 2020 to the primary completion date, 30 Jul 2029
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The presence of other neurological diseases that may cause brain dysfunction (such as depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, normal intracranial pressure hydrocephalus, etc.);
  • The presence of other systemic diseases that may cause cognitive impairment (such as liver dysfunction, renal dysfunction, thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.);
  • Suffering from a disease that makes it impossible to cooperate with cognitive examinations;

Other

  • The presence of contraindications to MRI;
  • The presence of mental and neurological retardation;
  • Refusing to draw blood;
  • Refusing to sign the informed consent form.

Who the study is looking for

  • Patients aged ≥50 and ≤85 years old, male or female;
  • Meet the diagnostic criteria for dementia or MCI;
  • Neuropsychological score: MMSE 15-28 points, CDR ≤ 1 point; ④ Patients and their families are informed and sign the informed consent form

Age in the registry: 50 years to 85 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chinese People's Liberation Army General Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
Coordinator of this site? Confirm its status
CangzhouChinaRecruiting
First Affiliated Hospital of Zhejiang University School of Medicine
Coordinator of this site? Confirm its status
HanzhongChinaRecruiting
Qilu Hospital of Shandong University, Qingdao Branch
Coordinator of this site? Confirm its status
QingdaoChinaRecruiting
Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting
The First Affiliated Hospital of China Medical University
Coordinator of this site? Confirm its status
ShenyangChinaRecruiting
The Second Hospital of Hebei Medical University
Coordinator of this site? Confirm its status
ShijiazhuangChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.